Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 9/20 | 0.43 |
| ▸ | CASP8 | Q14790 | 5/20 | 0.43 |
| ▸ | CASP7 | P55210 | 5/20 | 0.43 |
| ▸ | CASP1 | P29466 | 4/20 | 0.43 |
| ▸ | CASP9 | P55211 | 2/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 3/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.40 |
| ▸ | BMP1 | P13497 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29802276 | 0.91 | ENPEP (0.50) | CASP3CASP8CASP1CASP9CASP6 | |
| SCHEMBL811845 | 0.88 | CASP1 (0.43) | GNPATCASP3CASP7CASP1CASP9 | |
| SCHEMBL29586208 | 0.88 | BACE1 (0.46) | CASP3CASP8CASP7CASP1BACE1 | |
| SCHEMBL29487532 | 0.88 | GNPAT (0.44) | GNPATCASP3CASP8CASP7CASP1 | |
| SCHEMBL7157952 | 0.88 | GNPAT (0.44) | GNPATCASP3CASP8CASP7CASP1 | |
| SCHEMBL6534663 | 0.87 | GNPAT (0.54) | GNPATCASP3CASP7CASP1CASP9 | |
| SCHEMBL7166591 | 0.87 | GNPAT (0.48) | GNPATCASP3CASP8CASP7CASP1 | |
| SCHEMBL22310788 | 0.86 | GNPAT (0.47) | GNPATCASP3CASP8CASP7CASP1 | |
| SCHEMBL31634368 | 0.83 | KDM4E (0.51) | GNPATCASP3CASP7CASP1CASP9 | |
| SCHEMBL7165565 | 0.82 | CASP3 (0.55) | CASP3CASP8CASP7CASP1CASP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12576076-B2 | Use of HSP70 as a regulator of enzymatic activity | Zevra Denmark A/S (DK) | 2026-03-17 | — | — | US | disclosed |
| WO-2025106671-A1 | PERSONALIZED PROGENITOR CELLS | IMMORTA BIO, INC. (US) | 2025-05-22 | — | — | WO | disclosed |
| US-20250075185-A1 | Orthopedic Regeneration by Inducible Pluripotent Stem Cell Derived Mesenchymal Stem Cells | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20240307366-A1 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | ZEVRA DENMARK AS (DK) | 2024-09-19 | — | — | US | disclosed |
| US-11938125-B2 | Use of Hsp70 as a regulator of enzymatic activity | Zevra Denmark A/S (DK) | 2024-03-26 | — | — | US | disclosed |
| EP-4285909-A2 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | Zevra Denmark A/S (DK) | 2023-12-06 | — | — | EP | disclosed |
| EP-3578195-B1 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | ZEVRA DENMARK AS (DK) | 2023-08-09 | — | — | EP | disclosed |
| US-20220374361-A1 | METHODS FOR INCREASING INTRACELLULAR ACTIVITY OF HSP70 | Zevra Denmark A/S (DK) | 2022-11-24 | — | — | US | disclosed |
| US-20220362234-A1 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | Zevra Denmark A/S (DK) | 2022-11-17 | — | — | US | disclosed |
| CN-109010830-B | Application of platelet related inhibitor in preparation of medicine for treating thrombocytopenia | 苏州大学 | 2022-06-07 | — | — | CN | disclosed |
| US-11304941-B2 | Use of HSP70 as a regulator of enzymatic activity | ORPHAZYME A/S (DK) | 2022-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576076-B2 | Use of HSP70 as a regulator of enzymatic activity | HSPB1, HSPA1B, HSPD1 | GNPAT 2208/4885CASP3 1360/4885CASP8 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.